Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Squamous Cell Carcinoma

Explore clinical trials studying Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

354 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Squamous Cell Carcinoma trial results

Recruiting

First in Human Study of SIM0610 in Solid Tumors

NCT07348211

Conditions
Adenocarcinoma, Advanced Solid Tumours, Bronchial Neoplasms, +31 more
Locations
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • the First Hospital of China Medical University Shenyang, Liaoning, China
  • The Affiliated Cancer Hospital of Shandong First Medical University& Shan Dong Cancer Hospital Jinan, Shandong, China
View Trial Details
Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Conditions
Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
Locations
  • California Research Institute Los Angeles, California, United States
  • BRCR Global Tamarac, Florida, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

NCT05793151

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +22 more
Locations
  • Washington University in St. Louis St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
  • Baylor College of Medicine Houston, Texas, United States
View Trial Details
Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT03556228

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +65 more
Locations
  • Providence Medical Foundation (site 209) Santa Rosa, California, United States
  • Hartford Hospital (site 210) Hartford, Connecticut, United States
  • The George Washington University Cancer Center (site 212) Washington D.C., District of Columbia, United States
  • Holy Cross Hospital (site 213) Fort Lauderdale, Florida, United States
View all 15 locations
View Trial Details

Related conditions